These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2733094)

  • 1. Differential hypomethylation of the c-myc protooncogene in bladder cancers at different stages and grades.
    Del Senno L; Maestri I; Piva R; Hanau S; Reggiani A; Romano A; Russo G
    J Urol; 1989 Jul; 142(1):146-9. PubMed ID: 2733094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal c-myc oncogene DNA methylation in human bladder cancer: possible role in tumor progression.
    Sardi I; Dal Canto M; Bartoletti R; Montali E
    Eur Urol; 1997; 31(2):224-30. PubMed ID: 9076471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
    Kunze E; Wendt M; Schlott T
    Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between the expression of oncogenes ras and c-erbB-2 and the biological behavior of bladder tumors.
    Ye DW; Zheng JF; Qian SX; Ma YJ
    Urol Res; 1993 Jan; 21(1):39-43. PubMed ID: 8096102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenes and bladder cancer.
    Malone PR; Visvanathan KV; Ponder BA; Shearer RJ; Summerhayes IC
    Br J Urol; 1985 Dec; 57(6):664-7. PubMed ID: 4084726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Her-2/neu protein overexpression and gene amplification in human transitional cell carcinoma of the bladder.
    Montie JE
    J Urol; 2005 Jun; 173(6):1921-2. PubMed ID: 15879779
    [No Abstract]   [Full Text] [Related]  

  • 7. [The mechanism of p16 gene inactivation in human bladder transitional cell carcinoma].
    Wu Y; Wu H; Ma T; Wu C
    Zhonghua Bing Li Xue Za Zhi; 1999 Feb; 28(1):39-41. PubMed ID: 11869511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EZH2 polycomb transcriptional repressor expression correlates with methylation of the APAF-1 gene in superficial transitional cell carcinoma of the bladder.
    Hinz S; Kempkensteffen C; Weikert S; Schostak M; Schrader M; Miller K; Christoph F
    Tumour Biol; 2007; 28(3):151-7. PubMed ID: 17541304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RUNX3 methylation as a predictor for disease progression in patients with non-muscle-invasive bladder cancer.
    Yan C; Kim YW; Ha YS; Kim IY; Kim YJ; Yun SJ; Moon SK; Bae SC; Kim WJ
    J Surg Oncol; 2012 Mar; 105(4):425-30. PubMed ID: 22311819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome 8 numerical aberration and C-MYC copy number gain in bladder cancer are linked to stage and grade.
    Mahdy E; Pan Y; Wang N; Malmström PU; Ekman P; Bergerheim U
    Anticancer Res; 2001; 21(5):3167-73. PubMed ID: 11848469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regularly methylated novel pro-apoptotic genes associated with recurrence in transitional cell carcinoma of the bladder.
    Christoph F; Weikert S; Kempkensteffen C; Krause H; Schostak M; Miller K; Schrader M
    Int J Cancer; 2006 Sep; 119(6):1396-402. PubMed ID: 16642478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-frequency mutation of Ha-ras and Ki-ras oncogenes in transitional cell carcinoma of the bladder.
    Olderøy G; Daehlin L; Ogreid D
    Anticancer Res; 1998; 18(4A):2675-8. PubMed ID: 9703927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression.
    Quentin T; Henke C; Korabiowska M; Schlott T; Zimmerman B; Kunze E
    Anticancer Res; 2004; 24(2B):1011-23. PubMed ID: 15161057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-erbB-2 amplification and identical p53 mutations in concomitant transitional carcinomas of renal pelvis and urinary bladder.
    Lunec J; Challen C; Wright C; Mellon K; Neal DE
    Lancet; 1992 Feb; 339(8790):439-40. PubMed ID: 1346710
    [No Abstract]   [Full Text] [Related]  

  • 15. Gene expression in superficial bladder cancer in a tumor-model-system (RBT).
    Knopf HJ; von Moorselaar RJ; Debruyne FM; Schalken JA
    Investig Urol (Berl); 1994; 5():76-9. PubMed ID: 7719325
    [No Abstract]   [Full Text] [Related]  

  • 16. Deoxyribonucleic acid content and survival rates of patients with transitional cell carcinoma of the bladder.
    al-Abadi H; Nagel R
    J Urol; 1994 Jan; 151(1):37-42. PubMed ID: 8254829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelic loss of chromosome 17p distinguishes high grade from low grade transitional cell carcinomas of the bladder.
    Olumi AF; Tsai YC; Nichols PW; Skinner DG; Cain DR; Bender LI; Jones PA
    Cancer Res; 1990 Nov; 50(21):7081-3. PubMed ID: 2208176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical analysis of bcl-2 expression in transitional cell carcinoma of the bladder.
    Shiina H; Igawa M; Urakami S; Honda S; Shirakawa H; Ishibe T
    J Clin Pathol; 1996 May; 49(5):395-9. PubMed ID: 8707954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic evidence of gene amplification in urothelial cancer--a possible mechanism of tumor invasiveness.
    Milasin J; Mićić S
    Urol Int; 1992; 48(3):258-60. PubMed ID: 1589912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The study of p53 gene mutation in human bladder cancer].
    Ding Q; Zhang Y; Sun X
    Zhonghua Wai Ke Za Zhi; 1995 Nov; 33(11):684-6. PubMed ID: 8731915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.